97842013

Information

  • Trademark
  • 97842013
  • Serial Number
    97842013
  • Filing Date
    March 16, 2023
    a year ago
  • Transaction Date
    April 20, 2024
    5 months ago
  • Status Date
    April 20, 2024
    5 months ago
  • Location Date
    April 20, 2024
    5 months ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    JOHNSON, CLINTON J
  • Attorney Docket Number
    375.026817
    Attorney Name
    Jennifer Sheehan Anderson
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
3
Case File Statements
  • DM0000: The mark consists of the term NUCLEIX in a stylized format with the letter "I" inverted such that the dot appears below the word.
  • GS0051: Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection or detection of or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; diagnostic reagents for medical purposes
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use
  • GS0441: Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing cancer screening services; providing screening services for chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
  • GS0421: Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays
Case File Event Statements
  • 3/20/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/6/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/7/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 12/13/2023 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/4/2024 - 8 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/4/2024 - 8 months ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/4/2024 - 8 months ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/20/2024 - 5 months ago
    8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 4/20/2024 - 5 months ago
    9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2